Loading clinical trials...

Tranexamic Acid as an Intervention in Placenta Previa | Clinical Trials | Clareo Health

COMPLETEDNANCT05688111

Tranexamic Acid as an Intervention in Placenta Previa

Antepartum hemorrhage (APH) due to placenta previa is an important cause of worldwide perinatal mortality and maternal morbidity in pregnant women

Lead sponsor: Hawler Medical University•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment146

Start dateDec 2022

Last updatedJan 27, 2025

Condition

Interventional Drug in Placenta Previa

Locations shown

Ariana kh. Jawad

Erbil, Kurdistan Region

Kurdistan Board for Medical speciality

Erbil, Kurdistan Region

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 27, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions